Sinopharm Group国药控股
Explore the data
Revenue
Source: Sinopharm 2020 Annual Reportwww1.hkexnews.hk/listedco/listconews/sehk/2021/0423/2021042300115.pdfNotes: 2020 revenue was reported in RMB and was converted to dollars using the exchange rate from November 5, 2021.
Source: Sinopharm 2020 Annual Reportwww1.hkexnews.hk/listedco/listconews/sehk/2021/0423/2021042300115.pdfNotes: 2020 revenue was reported in RMB and was converted to dollars using the exchange rate from November 5, 2021.
Employees
Source: Sinopharm Websitewww.sinopharm.com/1398.html
Source: Sinopharm Websitewww.sinopharm.com/1398.html
Valuation
Source: Yahoo Financefinance.yahoo.com/quote/SHTDY/key-statisticsNotes: Valuation is reported as market capitalization. It was converted from HKD using the exchange rate from September 13, 2022 13:49:40.
Source: Yahoo Financefinance.yahoo.com/quote/SHTDY/key-statisticsNotes: Valuation is reported as market capitalization. It was converted from HKD using the exchange rate from September 13, 2022 13:49:40.
Overview
Source: Fortunefortune.com/2021/08/31/china-covid-vaccine-sinovac-sinopharm-delta-variant-effective/Source: Financial Timeswww.ft.com/content/91cbc7ef-808d-448a-a832-2384f045dc35Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
Source: Fortunefortune.com/2021/08/31/china-covid-vaccine-sinovac-sinopharm-delta-variant-effective/Source: Financial Timeswww.ft.com/content/91cbc7ef-808d-448a-a832-2384f045dc35Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
Sinopharm Group Co., Ltd. is a state-owned drug researcher, distributor, and manufacturer best known globally for its COVID-19 vaccine, which was the No. 3 most-used in the world as of September 2021.
Sinopharm’s vaccine, the first Chinese jab to be given emergency approval by the World Health Organization, has made up a significant proportion of the 2 billion doses administered in China and 693 million sent abroad, along with peer company Sinovac Biotech’s shot. Also as of September, Sinopharm’s vaccines have been approved in 11 countries and authorized for emergency use or market access in 107 countries and regions. Sinopharm signed an agreement in July 2021 to provide 170 million COVID-19 vaccine doses to COVAX, the global initiative to distribute vaccines to low- and middle-income countries.
The company has reportedly also reached cooperation deals with the United Arab Emirates, Serbia, Morocco and Hungary to produce its vaccines locally. Its chairman said it is now in discussion with African, Southeast Asian, and American countries to build local vial-filling and packaging plants.
The company has an annual production capacity of 7 million doses and is currently developing an mRNA vaccine. It is a subsidiary of Sinopharm Industrial Investment, which was a joint venture of Fosun Pharmaceutical and state-owned China National Pharmaceutical.
Fast facts
- Full ENGLISH Name
- Sinopharm Group Co., Ltd.
- Full Chinese Name
- 国药控股股份有限公司
- WEBSITE
- https://www.sinopharmholding.com
- TICKER SYMBOL
- 1099.HK
- Headquarters
- Floor, No. 385 Longhua East Road, Huangpu District, Shanghai
- Year founded
Source: Qichachawww.qcc.com/firm/0604fbd802d077219bc569df2934eca9.html
- 2003
- POINT OF CONTACT
Phone number: 021-23052666
Email: chenjie33@sinopharm.com- COMPANY TYPE
- Publicly Traded SOE
- REGISTERED CAPITAL
- USD 357.1 M
- LEGAL Representative
- Yú Qīngmíng
- IPO DATE
- 2009 (HKEX)
Ownership
| English Name | Chinese Name | Percent Ownership | Ultimate Beneficiary | Share Class |
|---|---|---|---|---|
Sinopharm Industry Investment
| 50.36% | A-shares | ||
|
China National Pharmaceutical Group
| 6.64% | A-shares | ||
|
FMR LLC
| 4.37% | |||
|
BlackRock
| 2.6% | |||
Yú Qīngmíng
| 于清明 | 0.0032% | ||
|
Líu Yǒng
| 刘勇 | 0.0019% |
Subsidiaries
| English Name | Chinese Name | Percent Held |
|---|
Leadership
| English Name | Chinese Name | Title |
|---|---|---|
|
Yú Qīngmíng
| 于清明 | Chairman |
|
Chén Qǐyǔ
| 陈启宇 | Vice Chairman |
|
Líu Yǒng
| 刘勇 | Executive Director |
|
Féng Rónglì
| 冯蓉丽 | Non-Executive Director |
|
Wén Déyōng
| 文德镛 | Non-Executive Director |
|
Hú Jiànwěi
| 胡建伟 | Non-Executive Director |
|
Mǎ Píng
| 马萍 | Non-Executive Director |
|
Lǐ Dōngjǐu
| 李东久 | Non-Executive Director |
|
Dèng Jīndòng
| 邓金栋 | Non-Executive Director |
|
Yú Wèifēng
| 俞卫锋 | Independent Non-Executive Director |
Latest News
-
- headline
- date
- source
- tags
DUE DILIGENCE
Military Affiliation
China has disclosed military-to-military shipments of Covid-19 shots manufactured by state-owned drugmaker Sinopharm totaling hundreds of thousands of doses. Many of the recipients, like Zimbabwe and Ethiopia, are important players in Chinese leader Xi Jinping’s trillion-dollar Belt and Road infrastructure initiative.